Insights

Market Expansion Opportunities Martin Imaging's focus on increasing access to PET MPI in outpatient and rural settings presents significant sales potential with hospital networks, community clinics, and outpatient practices seeking advanced diagnostic tools to serve underserved populations.

Technological Adoption The company's cutting-edge PET imaging technology offers hospitals and private practices an upgrade opportunity from older systems, particularly in oncology, neurology, and cardiology, where improved diagnostics can drive competitive advantage.

Underserved Demographics Targeting cardiology and neurology practices that serve women, obese patients, and complex cases presents a strategic entry point, as these groups currently benefit from enhanced diagnostic precision and reduced radiation exposure.

Partnership Potential Collaborations with academic centers, community hospitals, and outpatient clinics focusing on cardiology, oncology, and neurology could rapidly expand the adoption of PET MPI, creating opportunities for sales and ongoing service agreements.

Growth in Diagnostic Imaging With a rising trend toward personalized medicine and advanced imaging, there is increasing demand among healthcare providers for innovative, lower-risk diagnostic tools—making Martin Imaging’s PET technology highly attractive for future procurement.

Martin Imaging Tech Stack

Martin Imaging uses 8 technology products and services including Microsoft 365, Font Awesome, Twemoji, and more. Explore Martin Imaging's tech stack below.

  • Microsoft 365
    Email
  • Font Awesome
    Font Scripts
  • Twemoji
    Font Scripts
  • TweenMax
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • Bootstrap
    UI Frameworks
  • prettyPhoto
    Web Tools And Plugins

Media & News

Martin Imaging's Email Address Formats

Martin Imaging uses at least 1 format(s):
Martin Imaging Email FormatsExamplePercentage
First@martinimaging.comJohn@martinimaging.com
100%

Frequently Asked Questions

Where is Martin Imaging's headquarters located?

Minus sign iconPlus sign icon
Martin Imaging's main headquarters is located at Destin, Florida 32541 United States. The company has employees across 1 continents, including North America.

What is Martin Imaging's official website and social media links?

Minus sign iconPlus sign icon
Martin Imaging's official website is martinimaging.com and has social profiles on LinkedIn.

What is Martin Imaging's NAICS code?

Minus sign iconPlus sign icon
Martin Imaging's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Martin Imaging have currently?

Minus sign iconPlus sign icon
As of December 2025, Martin Imaging has approximately 6 employees across 1 continents, including North America. Key team members include Chief Financial Officer: G. J. A.. Explore Martin Imaging's employee directory with LeadIQ.

What industry does Martin Imaging belong to?

Minus sign iconPlus sign icon
Martin Imaging operates in the Medical Equipment Manufacturing industry.

What technology does Martin Imaging use?

Minus sign iconPlus sign icon
Martin Imaging's tech stack includes Microsoft 365Font AwesomeTwemojiTweenMaxjQueryWP EngineBootstrapprettyPhoto.

What is Martin Imaging's email format?

Minus sign iconPlus sign icon
Martin Imaging's email format typically follows the pattern of First@martinimaging.com. Find more Martin Imaging email formats with LeadIQ.

Martin Imaging

Medical Equipment ManufacturingFlorida, United States2-10 Employees

By expanding access to this cutting-edge technology, Martin Imaging, Inc. is seeking to improve the standard of care for several currently underserved populations, particularly women, for whom the current generation of technologies is inadequate for proper diagnosis. Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI) is the preferred test when compared to other methods of cardiac assessment due to superior image quality, significantly lower radiation exposure, the ability to identify and quantify risk, and the ability to successfully guide therapy in patients with known or suspected coronary artery disease (CAD). The high sensitivity, specificity and diagnostic accuracy allows PET MPI to outperform other non-invasive approaches used to evaluate disease, especially in women, obese patients and those who have previously undergone Coronary Artery Bypass Grafts (CABG). 

Despite the superior performance of PET MPI in all patient types as a strong prognostic and risk stratification tool, it is still significantly underutilized as a modality, due to the limited number of Cardiac PET programs currently in existence throughout the United States. This low adoption rate continues to limit access to care and testing for patients who might otherwise benefit from a PET MPI. In addition to cardiology, PET imaging is an important diagnostic, planning and treatment tool for oncology and neurology. While such procedures are widely used in hospital and academic settings, they remain underutilized in outpatient office settings, with limited access in the rural and community settings.

Nuclear cardiologists in private or integrated practices, neurologists specializing in the aging brain/memory clinics, oncologists with older systems looking to upgrade to newer advanced technologies, and radiation oncologists looking to bring PET/CT imaging for treatment planning and staging to their current radiation therapy setting, all benefit from the improved patient outcomes.

Section iconCompany Overview

Headquarters
Destin, Florida 32541 United States
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    Martin Imaging's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Martin Imaging's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.